Nalaganje...
Extended interval dosing of natalizumab: a two-center, 7-year experience
BACKGROUND: The enthusiasm for natalizumab, a highly efficacious agent in the treatment of multiple sclerosis (MS), has been tempered by the risks of progressive multifocal leukoencephalopathy associated with its use, and strategies to minimize those risks are of great interest. Extended interval do...
Shranjeno v:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
SAGE Publications
2014
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4206618/ https://ncbi.nlm.nih.gov/pubmed/25342976 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285614540224 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|